Prot# 2689-CL-0005: A Phase 1 Study of AC220 (ASP2689) in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date10/24/1110/24/17

Funding

  • Astellas Pharma US. Inc. (2689-CL-0005)